Search filters

List of works by Stefan Smesny

210. NEURAPRO: A Multi-center RCT of Omega-3 Polyunsaturated Fatty Acids Versus Placebo in Young People at Ultra-High Risk of Psychotic Disorders: Medium-Term Outcome.

scientific article published on 20 March 2017

22. The Effects of Antidepressant use on Clinical Outcomes in the NEURAPRO-E Trial.

scientific article

31P-MR spectroscopy in monozygotic twins discordant for schizophrenia or schizoaffective disorder

scientific article published on 03 November 2011

Aging effects on regional brain structural changes in schizophrenia

scientific article

Alterations of niacin skin sensitivity in recurrent unipolar depressive disorder

scientific article published on 8 February 2010

Antipsychotic drug effects on left prefrontal phospholipid metabolism: a follow-up 31P-2D-CSI study of haloperidol and risperidone in acutely ill chronic schizophrenia patients

scientific article published on 17 April 2012

Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data

scientific article published on 01 June 2021

Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia

scientific article published on 6 June 2015

Auditory hallucinations and brain structure in schizophrenia: voxel-based morphometric study

scientific article published in May 2010

Bioactive lipids in schizophrenia

scientific article published in April 2006

Brain structural correlates of schizotypy and psychosis proneness in a non-clinical healthy volunteer sample

scientific article

Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study

scientific article published on 12 December 2014

Brain structure in schizophrenia vs. psychotic bipolar I disorder: A VBM study

scientific article

Cannabinoids influence lipid-arachidonic acid pathways in schizophrenia.

scientific article published on 21 February 2007

Clinical trajectories in the ultra-high risk for psychosis population

scientific article published on 18 February 2018

Cognitive function in euthymic bipolar disorder (BP I) patients with a history of psychotic symptoms vs. schizophrenia

scientific article published on 7 August 2015

Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

scientific article published on 11 March 2020

Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

scientific article published on 10 July 2019

Corrigendum: Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial

scientific article published on 10 June 2020

Critical reappraisal of a catechol-O-methyltransferase transversion variant in schizophrenia

scientific article published on 12 January 2010

Decreased phospholipase A2 activity in cerebrospinal fluid of patients with dementia

scientific article published on 27 June 2008

Default mode network activity in schizophrenia studied at resting state using probabilistic ICA.

scientific article published on 10 May 2012

Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?

scientific article

Do neuroleptics alter the cerebral intracellular pH value in schizophrenics?-a (31)P-MRS study on three different patient groups

scientific article published in June 2002

Effects of lorazepam on the neuromagnetic mismatch negativity (MMNm) and auditory evoked field component N100m.

scientific article

Effects of olanzapine on 31P MRS metabolic markers in schizophrenia

scientific article

Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis - Results of the randomized controlled Vienna omega-3 study.

scientific article published on 23 January 2017

Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis

scientific article

Endophenotype properties of niacin sensitivity as marker of impaired prostaglandin signalling in schizophrenia

scientific article published in August 2007

F24. OMEGA-6 PUFA METABOLISM DISTURBED IN PHOSPHO- AND SPHINGOLIPIDS IN NEUROLEPTIC-NAïVE FIRST-EPISODE SCHIZOPHRENIA PATIENTS – A FATTY ACID PROFILING STUDY IN FIVE LIPID FRACTIONS.

scientific article published in April 2018

F9. ALTERATIONS OF NEURONAL METABOLISM IN PATIENT SUBGROUPS AT ULTRA-HIGH RISK FOR PSYCHOSIS ACCORDING TO PACE CRITERIA – A 1H/31P-MR-SPECTROSCOPY STUDY.

scientific article

Fluorometric assays of phospholipase A2 activity with three different substrates in biological samples of patients with schizophrenia

scientific article

Frequency domains of resting state default mode network activity in schizophrenia

GSK3B and schizophrenia: a case not closed

scientific article published on 24 November 2009

Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophrenia

scientific article published on 25 September 2012

Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients

scientific article

Hippocampal metabolism and prefrontal brain structure: A combined 1H-MR spectroscopy, neuropsychological, and voxel-based morphometry (VBM) study

scientific article

Hippocampal structure, metabolism, and inflammatory response after a 6-week intense aerobic exercise in healthy young adults: a controlled trial

scientific article

Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.

scientific article

Machine learning based prediction and the influence of complement – Coagulation pathway proteins on clinical outcome: Results from the NEURAPRO trial

scientific article published in 2022

Metabolic mapping using 2D 31P-MR spectroscopy reveals frontal and thalamic metabolic abnormalities in schizophrenia

scientific article published on 29 December 2006

NEURAPRO-E study protocol: a multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders.

scientific article published on 16 August 2015

Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial

scientific article published on 14 December 2018

Neurometabolic patterns of an "at risk for mental disorders" syndrome involve abnormalities in the thalamus and anterior midcingulate cortex

scientific article published on 19 May 2020

Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis

scientific article published on 19 February 2016

Omega-3 fatty acids and neurocognitive ability in young people at ultra-high risk for psychosis

scientific article published on 06 September 2020

Opening the Black Box of Cognitive-Behavioural Case Management in Clients with Ultra-High Risk for Psychosis

scientific article

Organic bipolar disorder occurring together with spontaneous intracranial hypotension

scientific article

PM485. Association between erythrocyte membrane fatty acids and psychopathology in individuals at ultra-high risk for psychosis

scientific article published on 27 May 2016

PM486. Disrupting GluR2-GAPDH Interaction Affects Axon and Dendrite Development.

scientific article published on 27 May 2016

Phospholipase A2 activity is associated with structural brain changes in schizophrenia

scientific article published on 18 May 2010

Phospholipase A₂ activity in first episode schizophrenia: associations with symptom severity and outcome at week 12.

scientific article

Polyunsaturated fatty acid biostatus, phospholipase A2 activity and brain white matter microstructure across adolescence

scientific article

Polyunsaturated fatty acids in emerging psychosis

scientific article published on January 2012

Polyunsaturated fatty acids in emerging psychosis: a safer alternative?

scientific article published on 27 May 2014

Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale.

scientific article published in May 2003

Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population

scientific article published on 17 June 2020

Predictors of longer-term outcome in the Vienna omega-3 high-risk study.

scientific article

Prefrontal glutamatergic emotion regulation is disturbed in cluster B and C personality disorders - A combined 1H/31P-MR spectroscopic study.

scientific article published on 7 November 2017

Prefrontal gyrification in psychotic bipolar I disorder vs. schizophrenia

scientific article published on 23 June 2015

Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

scientific article published on 6 June 2019

Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study

scientific article

Resting state functional connectivity of the hippocampus along the anterior-posterior axis and its association with glutamatergic metabolism.

scientific article

S136. A NOVEL APPROACH FOR DEVELOPING PREDICTION MODEL OF TRANSITION TO PSYCHOSIS: DYNAMIC PREDICTION USING JOINT MODELLING.

scientific article

Serum S100B Protein is Specifically Related to White Matter Changes in Schizophrenia

scientific article published on 8 March 2016

Skin ceramide alterations in first-episode schizophrenia indicate abnormal sphingolipid metabolism

scientific article published on 15 May 2012

State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.

scientific article published on 08 June 2017

Superior temporal metabolic changes related to auditory hallucinations: a (31)P-MR spectroscopy study in antipsychotic-free schizophrenia patients

scientific article published on 3 July 2013

T23. DYNAMICS OF NEURONAL METABOLISM AFTER THE ACUTE ONSET OF PSYCHOSIS – A TWO YEARS FOLLOW-UP 1H/31P-MR-SPECTROSCOPY STUDY IN NEUROLEPTIC NAïVE UHR TRANSITION PATIENTS.

scientific article published in April 2018

T25. ALTERATIONS OF PLASMA PHOSPHOLIPID FATTY ACID PROFILES ARE ASSOCIATED WITH LOCAL BRAIN STRUCTURAL ABNORMALITIES IN NEUROLEPTIC NAïVE FIRST-EPISODE PSYCHOSIS PATIENTS.

scientific article published in April 2018

T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION.

scientific article

T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY.

scientific article

Thalamocortical connectivity during resting state in schizophrenia

scientific article published on 27 July 2013

The influence of age and gender on niacin skin test results - implications for the use as a biochemical marker in schizophrenia.

scientific article published in September 2004

The topical niacin sensitivity test: an inter- and intra-rater reliability study in healthy controls

scientific article published on 24 July 2008

Trajectories of symptom severity and functioning over a three-year period in a psychosis high-risk sample: A secondary analysis of the Neurapro trial

scientific article published on 21 November 2019

Paulina is supported by:

About Paulina

Help